A Study of SHR-A1811 in Subjects With Advanced Malignant Solid Tumors

Clinical trial NCT04446260 · COMPLETED

Trial details

NCT number: NCT04446260
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2020-09-07
Primary completion: 2025-06-04
Enrollment: 396

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.